The document discusses material management in the pharmaceutical industry. It covers various topics related to material management including definitions, objectives, purchasing, storage, and handling of raw materials, packaging materials, intermediates, rejected materials, and other item types. Proper documentation, labeling, storage conditions, and quality control are important for ensuring materials are suitable for use in manufacturing pharmaceutical products. The key goal of material management is to source high quality input materials and control their flow through the manufacturing process to deliver quality finished products on time.
Document Maintenance in Pharmaceutical IndustryNAKUL DHORE
Document Maintenance in Pharmaceutical Industry.
By_ NAKUL DHORE
❖ Introduction
❖ Batch Formula Record
❖ Master Formula Record
❖ SOPs
❖ Quality Audit
❖ Quality Review & Quality Documentation
❖ Reports & Documents
❖ Distribution Records
❖ MCQs
Quality Assurance
As per B.PHARM 3rd Year Semester-6
(PCI Syllabus New)
Document Maintenance in Pharmaceutical IndustryNAKUL DHORE
Document Maintenance in Pharmaceutical Industry.
By_ NAKUL DHORE
❖ Introduction
❖ Batch Formula Record
❖ Master Formula Record
❖ SOPs
❖ Quality Audit
❖ Quality Review & Quality Documentation
❖ Reports & Documents
❖ Distribution Records
❖ MCQs
Quality Assurance
As per B.PHARM 3rd Year Semester-6
(PCI Syllabus New)
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
A detailed study of the organisation and personnel involved in the pharmaceutical industry. These are involved in the guidelines of Good Manufacturing Practices.
Quality control on secondary packaging materialsAnupriyaNR
Presentation on quality control tests for the secondary packaging materials. Includes the materials used for secondary packaging, ideal properties of the secondary packaging material and various test procedures used for the quality control of the packaging materials.
Unit 2 organization and personnel and permisies himanshuhimanshu kamboj
pharmaceutical quality assurance
b pharma 6th sem
Personnel objectives
Personnel qualifications
Personnel responsibilities
Key personnel
Responsibilities of the head of the production department
Responsibilities of the head of quality control department
Training
Personnel hygiene
Premises
Layout of pharmaceutical industry
Areas of premises
Environmental control in sterile areas
Equipment and raw materials
Stages of equipment
Cleaning and maintenance
Raw materials
Steps involved in purchase procedure
Maintenance of stores
Storage conditions
General Principles of Analytical Method of Validation.pdfTamannaKumari8
Validation is the process of establishing documentary evidence demonstrating that a procedure, process, activity carried out in
testing and then production maintain the desirable level of compliance all stages.
The process of providing the analytical procedure is acceptable or its intended us.(ICH Q
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
Unit 4 Document maintenance in Pharmaceutical Industry.pptxAshwiniBhoir2
Document maintenance in pharmaceutical industry: Batch Formula Record, Master Formula
Record, SOP, Quality audit, Quality Review and Quality documentation, Reports and
documents, distribution records.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
A detailed study of the organisation and personnel involved in the pharmaceutical industry. These are involved in the guidelines of Good Manufacturing Practices.
Quality control on secondary packaging materialsAnupriyaNR
Presentation on quality control tests for the secondary packaging materials. Includes the materials used for secondary packaging, ideal properties of the secondary packaging material and various test procedures used for the quality control of the packaging materials.
Unit 2 organization and personnel and permisies himanshuhimanshu kamboj
pharmaceutical quality assurance
b pharma 6th sem
Personnel objectives
Personnel qualifications
Personnel responsibilities
Key personnel
Responsibilities of the head of the production department
Responsibilities of the head of quality control department
Training
Personnel hygiene
Premises
Layout of pharmaceutical industry
Areas of premises
Environmental control in sterile areas
Equipment and raw materials
Stages of equipment
Cleaning and maintenance
Raw materials
Steps involved in purchase procedure
Maintenance of stores
Storage conditions
General Principles of Analytical Method of Validation.pdfTamannaKumari8
Validation is the process of establishing documentary evidence demonstrating that a procedure, process, activity carried out in
testing and then production maintain the desirable level of compliance all stages.
The process of providing the analytical procedure is acceptable or its intended us.(ICH Q
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
Unit 4 Document maintenance in Pharmaceutical Industry.pptxAshwiniBhoir2
Document maintenance in pharmaceutical industry: Batch Formula Record, Master Formula
Record, SOP, Quality audit, Quality Review and Quality documentation, Reports and
documents, distribution records.
Good Manufacturing Practices.
Basic rules of GMP
Various aspects of GMP.
How do GMP change.
Comparison of GMP.
Quality assurance
Principles of QA
Functions of QA department.
Documentation
Importance of documentation of records
Important areas of documentation
Components of documentation
ANALYSIS OF RAW MATERIALS, FINISHED PRODUCTS, PACKAGING MATERIALS, IPQC, CPCS...Khadeeja6
RAW MATERIALS
It is basically the chemical ingredients of a process. starting material, in production of final product.
FINISHED PRODUCTS
Marketable product, transportable pack, salable pack
PACKAGING MATERIAL
Providing presentation, protection, identification, information, containment, convenience compliance, integrity and stability for a product during storage, transportation display and until it is consumed or throughout its shelf life.
IPQC
Providing accurate, specific and definite description of the procedures to be employed from the receipt of raw materials to the release of the finished dosage form.
CPCSEA GUIDELINES
Role of CPCSEA is to monitor animal experiments through ethics committees set up in institutions (IAEC)
CPCSEA Nominee -important link between CPCSEA and IAEC
IAEC scrutinize all project proposals for experimentation on animals.
The validity of IAEC is for 3 years.
pratik ghive cGMP According to schedule Mpratikghive82
Pratik Ghive Current Good Manufacturing Practices (cGMP) Guidelines According to schedule M Cover all guidelines as per Drug and cosmetic act 1940 and ICH guidelines
Analysis of Raw materials…..
This topic comes under Quality Control and Quality Assurance…….
This is useful for M.Pharm (Pharmaceutical Quality Assurance) Students who studying in Fist year sem I......
This Presentation Contain following...
#Definition
#Purchase Specification
#GMP & WHO guidelines for handling of raw materials
#Control on Raw Materials
#Sampling of Raw Materials
#Raw Materials Testing
Thanks for Help and Guidance of Dr. F. A. Tamboli Sir and Dr.Mrs. N.M.Bhatia Madam
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
4. INTRODUCTION:
• The prime objective of pharmaceutical manufacturing operation is to produce
finished pharmaceutical products from active, raw materials and various packaging
material.
• The quality of finished products produced solely depends upon the quality
input and hence material management becomes a very important activity in
pharmaceutical manufacturing operations.
• All incoming materials should be quarantine immediately after receipt or processing
until they are released for use or distribution.
• All materials and products should be stored under appropriate conditions,
established by the manufacturer.
• All items must be handled in such a way that no contamination on mix up takes
place.
4
5. • All materials and products should be stored under
appropriate conditions, established by the manufacturer
and user.
• These should be stored in an orderly fashion to permit
batch segregation by
FIRST IN – FIRST OUT(FIFO) and
FIRST EXPIRY- FIRST OUT(FEFO) rule.
• There shall be written procedures for all activity carried
out related to material handling eg; identification, storage,
handling, sampling, testing and approval.
5
6. DEFINITION
• According to The International Federation of Purchasing and Materials
Management defines material management as;
• “A total concept having its definite organization to plan and control all
types of materials, its supply, and its flow from raw stage to finished
stage so as to deliver the product to customer as per his requirements in
time.”
• “This involves materials planning, purchasing, receiving, storing,
inventory control, scheduling, production, physical distribution
and marketing. “
6
7. Objectives and Functions of Material Management
Efficient material
planning.
Buying or
purchasing
Receiving and
procuring.
Storage and
inventory control.
Quality
assurance.
Primary
objective Product
scheduling.
Material
handling.
Skilled
workers.
Standardizatio
n
Quality
control.
Secondary
objectives
7
8. PURCHASING
Following points should be considered regarding purchasing of
pharmaceutical material:
i. All materials should be purchased against and approved and adequate
specification which clearly states quality of material, physical
specification, chemical specification, microbiological specification etc.
ii. The parameters include specific characteristics like bulk density,
particle size, crystalline or amorphous nature, specificity of isomer etc.
iii. The raw material and packaging material should be purchased by
biased who are trained and possess sufficient technical knowledge.
Documents Required
SOP for vendor certification
9. RAW MATERIALS
• In case of raw materials following points should be considered.
• Supplier of the raw material should have his name listed in the company’s approved
vendor list.
• All raw materials ,must be checked for the following things :
Name of the manufacturer.
Name of the product.
Batch number.
Date of manufacture.
Date of expiry.
Quantity receive.
Condition of container.
9
10. • Sampling of these received materials should take place in specific
sampling booths by QC person only and the container must be
labeled accordingly.
• All received material must be properly identified with their status
i.e. product name, batch number , code number ,sterility status etc.
• Labeling should be done along with the following information:
Name and internal code number of product.
Batch number .
Status of material eg: QUARANTINE, on test, released,
rejected etc.
Expiry date of the product.
Storage conditions eg: low temperature, low humidity
etc. 10
11. • Containers from which sample has been taken must be identified .
• Only material released by Q.C department and within their shelf life should be used.
• Each dispensed material should be weighed or volume should be independently checked
and recorded.
• Materials dispensed from each batch of the final product should be kept together and
conspicuously labeled.
• All dispensed materials must be recorded in a chronological order of date and time.
DOCUMENTS REQUIRED:
• List of approved vendors .
• List of material classified according to storage condition.
• SOP of sampling , storage and dispensing of material.
• Register of sampling.
11
13. • PRIMARY PACAKGING MATERIALS: Materials which come in direct
contact of the medicinal product eg: Bottle , vials.
• SECONDARY PACKAGING MATERIALS: Materials which come in
contact with primary packaging materials eg: Labels and cartons .
13
14. • PRINTED PACKAGING MATERIALS: All packaging materials which
have anything printed on it such material include labels, foils etc.
TERTIARY PACKAGING MATERIALS: All packaging material other
than those that are covered in the above three categories.
14
15. The purchase, handling and
control of primary and
printed packaging material
shall be as for raw material.
Printed packaging material
should be stored securely in
lock and key system
Each material should be given a
specific identification number.
Outdated printed packaging
material should be destroyed
All product should be
checked for identity, safety
and purity.
Access to storage area
should be limited to
authorised person only.
A separate sampling room
must be provided for
sampling of packaging
materials.
15
16. DOCUMENT REQUIRED
A classified list of all packaging material.
List of approved vendor.
List of material based on storage.
Sampling and dispensing register In chronological
order.
16
17. INTERMEDIATE AND BULK PRODUCTS
• In pharmaceutical industry normally main or central ware house is responsible for
management of raw , packaging and finished products . However intermediate and bulk
product storage is the responsibility of production department.
• Intermediate or bulk product may be defined as the material , which has started
processing but not yet got converted into finished product eg:
1) granulated material ready for compression .
2) filtered liquids for oral or injectables.
• These products should be kept under appropriate storage conditions of temperature ,
relative humidity.
DOCUMENT REQUIRED :
• List of categories of intermediate and bulk products
17
18. REJECTED AND RECOVERED MATERIALS
• Reprocess and retest the materials to see whether it meets our specific
requirements.
• Destroy or send it to the supplier.
• Following points should be considered in this regards:
Rejected materials and products should clearly marked as such and stored
separately in restricted areas.
Such areas in industry are normally painted RED in color to make it distinguishable
easily. Such materials should either be returned to the suppliers or, where
appropriate, reprocessed or destroyed.
18
19. Rejected production batches should be reprocessed in exceptional situations.
The need for additional testing of any finished product that has been reprocessed or into,
which a recovered product has been added should be considered by the Q.C.
department.
DOCUMENT REQUIRED:
SOP on handling of rejected materials.
Record of disposal of rejected materials.
SOP on handling of recovered materials.
Record of disposal of recovered materials.
19
21. RECALLED PRODUCTS
• Products which are already distributed or sold, may be required at times to be recalled
from market for various reasons.
• Such recalled product should be clearly identified and stored separately in a secure
area until a decision is taken on their fate. Such decision should be made a soon as
possible.
DOCUMENT REQUIRED
• SOP on handling of recalled products.
• Records of recalled products and action taken on such recalled product.
21
22. • Pharmaceutical product can be returned from market for various reasons, e.g., quality
problems, accidental damage of goods etc.
• Physically examine the condition of the goods returned.
• Ask Q.C. department to evaluate the quality of the goods received and take a decision on
whether these products can be reprocessed and recovered or needs to be destroyed.
• If it is possible to reprocess and recover then such products after reprocessing and retesting
may be considered for relabeling, repacking and reselling the same.
• Q.C. department should evaluate all aspects like condition of the received material, time
elapsed since it was first processed etc. along with the chemical, microbiological or any other
technical evaluations.
RETURNED GOODS
22
23. REAGENTS AND CLTURE MEDIA
Following points should be considered regarding management of reagents and culture media :
• All reagents and culture media should be recorded upon receipt or preparation.
• Reagents made up in the laboratories should be prepared according to written procedures
and appropriately labeled. Such labels should indicate following information viz.
Name of the reagent.
Nominal concentration.
Standardization factor.
Shelf life.
Date when re-standardization is required.
The storage conditions.
Name/Signature and date of the person who has prepared and standardized
the required.
23
24. • Both positive and negative control should be applied to verify suitability
of the culture media. The size of the inoculums used in positive controls
should be appropriate to the sensitivity required.
DOCUMENT REQUIRED :
• Register of reagents and culture media.
24
25. WASTE MATERIALS
• Thrash : Which do not have any resale value and may be disposed off by proper method
depending upon the nature of the trash.
• Scrap : Which do gave a resale value and may be solid to scrap dealers, after proper
segregation.
• Before disposal of these materials, they can be segregated in different categories :
Paper
Aluminum foils
Plastic
Glass
Metallic containers etc.
25
26. • Safety of the materials to be disposed must be considered;
particularly flammable solvent drums must be washed thoroughly
before disposal since they pose a potential danger of fire or
explosion.
• Documents required :
• SOP and Records of handling waste work materials.
26
27. REFERENCE STANDARD
• Reference standards may be available in the form of official reference
standards.
• Reference standards prepared by the producer should be tested, released and
then stored in the same way as official standards.
• They should be kept under the responsibility of a designated person in
secure area.
• Official reference standards should be prepared and used only for the purpose
described in the appropriate monograph.
DOCUMENT REQUIRED
• SOP and Records on handling of reference and working standards.
27
28. MISCELLANEOUS MATERIALS
• All those materials, which do not specifically fall under the category of R.M/P.M.
Intermediate, bulk and finished pharmaceuticals may be considered under this category of
miscellaneous materials.
• Such materials like, rodenticides , insecticides , fumigating agents and sanitizing
materials fall under this category, these materials should not be permitted to contaminate
equipment, raw materials, packaging materials, in process materials or finished products.
DOCUMENT REQUIRED
• List of miscellaneous materials handled in pharmaceutical plants.
• SOP on handling of miscellaneous materials.
28
29. MISCELLANEOUS MATERIALS
• All those materials, which do not specifically fall under the category of
R.M/P.M. Intermediate, bulk and finished pharmaceuticals may be considered
under this category of miscellaneous materials.
• Such materials like, rodenticides , insecticides , fumigating agents and
sanitizing materials fall under this category, these materials should not be
permitted to contaminate equipment, raw materials, packaging materials, in
process materials or finished products.
DOCUMENT REQUIRED
• List of miscellaneous materials handled in pharmaceutical plants.
• SOP on handling of miscellaneous materials.
29
31. DOCUMENT TITLE : SOP ON RECEIPT , STORAGE
AND SAMPLING OF RAW MATERIALAND
PACKAGING MATERIAL
This SOP should cover the following points in each area of activities :
• RECEIPT OF MATERIALS
1)All incoming materials must be visually examined for :
Intact container lids and seals
Evidence of any physical damage to the containers
Evidence of rodent or insect infestation
Proper labelling
2)Following things must be checked and recorded :
Date of receipt.
Control number assigned by the manufacturer, with name of product and batch
number.
Quantity received.
Name of supplier.
• Purchase order number.
31
32. 3)STORAGE OF MATERIALS :
• Following points should be covered .
External cleaning of the container after receiving and before storage .
Quantity verification.
Storage in specified area as per storage conditions eg:
Room temperature area.
Low temperature area.
Low humidity area.
• Storage as per quarantine status of materials eg:
Received materials.
Sampled materials.
Rejected materials.
32
34. Document Title: Sop On Dispensing Of Materials .
It should cover the following points.
• Person authorized to requisition the materials and dispense and issue the
material.
• Precaution before dispensing the material.
Verification of balance for calibration.
Verification of environmental condition.
Verification of cleanliness and sanitary conditions of the utensils and area
Proper uniform of people.
Working of reverse laminar air flow unit and showing requisite air pressure
differential.
Properly authorised requisition.
Availability of correct material in required quantity. 34
35. • Precaution during dispensing of material:
Verification of each item during weighing.
Recording correct weight or volume of material.
Fixing proper labels.
Opening and closing of the container properly.
Filling the dispensing document correctly.
• Precaution after dispensing the materials:
Segregation of the dispensed material properly.
Retiring the balanced material to the store.
Cleaning the area and utensils for dispensing.
The dispensing records eg dispensing log book should be completed immediately and
the activity must be closed.
35
36. Document Title: SOP On Handling Of Rejected
Materials
• This SOP covers the following points :
How rejected materials are identified?
How these materials are stored?
How records should be maintained ?
How these materials are disposed off ?
What precautions are taken to deal with rejected printed materials ?
What precautions are taken to avoid accidental use of rejected materials ?
36
37. REFRENCES:
Potdar. M.; Pharmaceutical Quality Assurance; Nirali prakashan; 4TH
EDITION (4.1-4.18) .
Roy.M, Dr. Sharma.P; Material management in industry: A Review ;
World journal of pharmaceutical research ; Volume (4) Issue number
:10; (1012-1031).
37